产品编号 :
ACVTJQ814
Cas No. :
1256937-27-5
包装规格
纯度
目录价
会员专享价
库存
数量
抱歉,暂无牌价信息
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
1256937-27-5
中文名称
Evolocumab单抗
英文名称
Evolocumab
别名
Evolocumab;AMG 145;Research Grade Evolocumab(DHJ24002);AMG-145,Ser/Thr Protease,Repatha,AMG 145,inhibit,atherosclerotic cardiovascular disease,Serine endopeptidases,PCSK9,Evolocumab,AMG145,Threonine proteases,hypercholesterolemia,LDLR,Inhibitor,Serine proteases;Evolocumab(anti-PCSK9);Research Grade Evolocumab;Evolocumab - solution - 5 mg/ml
标准英文名
2-((cyclopropylmethyl)imino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--2-(butylimino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--2-(ethylimino)-3-(1-(4-fluorophenyl)ethyl)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--3-(1-(4-fluorophenyl)ethyl)-2-((3-hydroxypropyl)imino)-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)imidazolidin-4-one--3-(1-(4-fluorophenyl)ethyl)-2-methoxy-5-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene)-3,5-dihydro-4H-imidazol-4-one (1/1/1/1/1)
分子式
C1 2 9 H1 3 5 F5 N2 4 O1 2
分子量
2308.65
精确分子量
2307.06
SMILES
CCCCN=C1NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CCN=C1NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.COC1=C(N2C=NC(C)=C2)C=CC(C=C2NC(=NCC3CC3)N(C(C)C3=CC=C(F)C=C3)C2=O)=C1.COC1=C(N2C=NC(C)=C2)C=CC(C=C2NC(=NCCCO)N(C(C)C3=CC=C(F)C=C3)C2=O)=C1.COC1=NC(=CC2=CC(OC)=C(N3C=NC(C)=C3)C=C2)C(=O)N1C(C)C1=CC=C(F)C=C1
标准SMILES
CCCCN=C1NC(=CC2=CC(OC)=C(C=C2)N2C=C(C)N=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CCN=C1NC(=CC2=CC(OC)=C(C=C2)N2C=C(C)N=C2)C(=O)N1C(C)C1=CC=C(F)C=C1.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1NC(=NCCCO)N(C(C)C2=CC=C(F)C=C2)C1=O.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1NC(=NCC2CC2)N(C(C)C2=CC=C(F)C=C2)C1=O.CC1=CN(C=N1)C1C=CC(=CC=1OC)C=C1N=C(OC)N(C(C)C2=CC=C(F)C=C2)C1=O
用途
Evolocumab is indicated for the treatment of homozygous familial hypercholesterolemia in adults and adolescents aged 12 years and older, and for the treatment of adults with atherosclerotic cardiovascular disease to reduce the risk of myocardial infarction, stroke, and coronary revascularization.
InChIKey
PUHBRGRYFZDQIV-UHFFFAOYSA-N